The COVID-19 Outbreak May Be Associated to a Reduced Level of Care for Breast Cancer. A Comparative Study with the Pre-COVID Era in an Italian Breast Unit
Abstract
1. Introduction
2. Methods
Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
Ethics Approval and Consent to Participate
References
- European Centre for Disease Prevention and Control. Available online: https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases (accessed on 24 June 2020).
- De Azambuja, E.; Trapani, D.; Loibl, S.; Delaloge, S.; Senkus, E.; Criscitiello, C.; Poortman, P.; Gnant, M.; Di Cosimo, S.; Cortes, J.; et al. ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer. ESMO Open 2020, 5, e000793. [Google Scholar] [CrossRef]
- Burki, T.K. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol. 2020, 21, 629–630. [Google Scholar] [CrossRef]
- Nepogodiev, D.; Bhangu, A.; Glasbey, J.C.; Li, E.; Omar, O.M.; Simoes, J.F.; Abbott, T.E.; Alser, O.; Arnaud, A.P.; Bankhead-Kendall, B.K.; et al. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: An international cohort study. Lancet 2020, 396, 27–38. [Google Scholar] [CrossRef]
- Schrag, D.; Hershman, D.L.; Basch, E. Oncology practice during the COVID-19 pandemic. JAMA 2020, 323, 2005. [Google Scholar] [CrossRef]
- Liotta, G.; Marazzi, M.C.; Orlando, S.; Palombi, L. Is social connectedness a risk factor for the spreading of COVID-19 among older adults? The Italian paradox. PLoS ONE 2020, 15, e0233329. [Google Scholar] [CrossRef]
- Biganzoli, L.; Cardoso, F.; Beishon, M.; Cameron, D.; Cataliotti, L.; Coles, C.E.; Bolton, R.C.D.; Trill, M.D.; Erdem, S.; Fjell, M.; et al. The requirements of a specialist breast centre. Breast 2020, 51, 65–84. [Google Scholar] [CrossRef] [PubMed]
- Vogler, S.A.; Lightner, A.L. Rethinking how we care for our patients in a time of social distancing during the COVID-19 pandemic. Br. J. Surg. 2020, 107, 937–939. [Google Scholar] [CrossRef]
- Balogun, O.D.; Bea, V.J.; Phillips, E. Disparities in cancer outcomes due to COVID-19-A tale of 2 cities. JAMA Oncol. 2020, 6, 1531. [Google Scholar] [CrossRef]
- Fancellu, A.; Sanna, V.; Sedda, M.L.; DelRio, D.M.; Cottu, P.; Spanu, A.; Giuliani, G.; Conti, M.; Piras, R.; Crivelli, P.; et al. Benefits of organized mammographic screening programs in women aged 50 to 69 years: A surgical perspective. Clin. Breast Cancer 2019, 19, e637–e642. [Google Scholar] [CrossRef]
- Albornoz, C.R.; Cordeiro, P.G.; Farias-Eisner, G.; Mehrara, B.J.; Pusic, A.L.; McCarthy, C.M.; Disa, J.J.; Hudis, C.A.; Matros, E. Diminishing relative contraindications for immediate breast reconstruction. Plast. Reconstr. Surg. 2014, 134, 363e–369e. [Google Scholar] [CrossRef]
- Fancellu, A.; Sanna, V.; Cottu, P.; Feo, C.F.; Scanu, A.M.; Farina, G.; Bulla, A.; Spanu, A.; Paliogiannis, P.; Porcu, A. Mastectomy patterns, but not rates, are changing in the treatment of early breast cancer. Experience of a single European institution on 2315 consecutive patients. Breast 2018, 39, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Siotos, C.; Lagiou, P.; Cheah, M.A.; Bello, R.J.; Orfanos, P.; Payne, R.M.; Broderick, K.P.; Aliu, O.; Habibi, M.; Cooney, C.M.; et al. Determinants of receiving immediate breast reconstruction: An analysis of patient characteristics at a tertiary care center in the US. Surg. Oncol. 2020, 34, 1–6. [Google Scholar] [CrossRef] [PubMed]
- Corsi, F.; Caruso, A.; Albasini, S.; Bossi, D.; Polizzi, A.; Msc, F.P.; Truffi, M. Management of breast cancer in an EUSOMA-accredited Breast Unit in Lombardy, Italy, during the COVID-19 pandemic. Breast J. 2020, 26, 1609–1610. [Google Scholar] [CrossRef] [PubMed]
- Di Pace, B.; Benson, J.R.; Malata, C.M. Breast reconstruction and the COVID-19 pandemic: A viewpoint. J. Plast. Reconstr. Aesthetic Surg. 2020, 73, 1357–1404. [Google Scholar] [CrossRef]
- Disis, M.L. Oncology and COVID-19. JAMA 2020, 324, 1141–1142. [Google Scholar] [CrossRef]
- Liang, W.; Guan, W.; Chen, R.; Wang, W.; Li, J.; Xu, K.; Li, C.; Ai, Q.; Lu, W.; Liang, H.; et al. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol. 2020, 21, 335–337. [Google Scholar] [CrossRef]
- Choi, J.J.; Jo, Y.Y.; Shin, Y.; Jung, W.S.; Lee, D.; Kim, K.Y.; Kwak, H.J. Remifentanil-sparing effect of pectoral nerve block type ii in breast surgery under surgical pleth index-guided analgesia during total intravenous anesthesia. J. Clin. Med. 2019, 8, 1181. [Google Scholar] [CrossRef]
- Garg, R.; Bhan, S.; Vig, S. Newer regional analgesia interventions (fascial plane blocks) for breast surgeries: Review of literature. Indian J. Anaesth. 2018, 62, 254–262. [Google Scholar] [CrossRef]
- Singh, P.M.; Borle, A.; Kaur, M.; Trikha, A.; Sinha, A. Opioid-sparing effects of the thoracic interfascial plane blocks: A meta-analysis of randomized controlled trials. Saudi J. Anaesth. 2018, 12, 103–111. [Google Scholar] [CrossRef]
- Exadaktylos, M.A.K.; Buggy, D.J.; Moriarty, F.D.C.; Mascha, P.E.; Sessler, M.D.I. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 2006, 105, 660–664. [Google Scholar] [CrossRef]
- Forget, P.; Vandenhende, J.; Berliere, M.; Machiels, J.-P.; Nussbaum, B.; Legrand, C.; De Kock, M. Do Intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis. Anesth. Analg. 2010, 110, 1630–1635. [Google Scholar] [CrossRef] [PubMed]
- Fancellu, A.; Perra, T.; Ninniri, C.; Cottu, P.; Deiana, G.; Feo, C.F.; Porcu, A. The emerging role of pectoral nerve block (PECS block) in breast surgery: A case-matched analysis. Breast J. 2020, 26, 1784–1787. [Google Scholar] [CrossRef] [PubMed]
- COVID Surg Collaborative; Nepogodiev, D.; Bhangu, A. Elective surgery cancellations due to the COVID-19 pandemic: Global predictive modelling to inform surgical recovery plans. Br. J. Surg. 2020. [Google Scholar] [CrossRef]
- Meredith, J.W.; High, K.P.; Freischlag, J.A. Preserving elective surgeries in the COVID-19 pandemic and the future. JAMA 2020, 324, 1725. [Google Scholar] [CrossRef] [PubMed]
- Kaufman, H.W.; Chen, Z.; Niles, J.; Fesko, Y. Changes in the number of US patients with newly identified cancer before and during the coronavirus disease 2019 (COVID-19) pandemic. JAMA Netw. Open 2020, 3, e2017267. [Google Scholar] [CrossRef] [PubMed]
Characteristic | Total (n = 83) | Group A—2020 (n = 42) | Group B—2019 (n = 41) | p Value |
---|---|---|---|---|
Age (mean ± SD) | 61.3 ± 12.6 | 62.0 ± 12.4 | 60.6 ± 13.9 | 0.62 |
Tumour size (mean, SD) | 17.7 ± 10.0 | 16.4 ± 9.2 | 18.9 ± 10.7 | 0.25 |
Tumour grade | 0.27 | |||
I | 15 (18.1%) | 7 (17.1%) | 8 (19.0%) | |
II | 48 (57.8%) | 27 (65.8%) | 21 (50.0%) | |
III | 20 (24.1%) | 7 (17.1%) | 13 (31.0%) | |
Tumor histology | 0.43 | |||
IDC | 59 (71.2%) | 30 (73.2%) | 29 (69.0%) | |
ILC | 12 (14.4) | 4 (9.7%) | 8 (19.0%) | |
DCIS | 12 (14.4) | 7 (17.1%) | 5 (12.0) | |
Positive Axillary lymph nodes | 11 (13.25%) | 4 (9.75%) | 7 (16.6%) | 0.35 |
ER positive | 71 (85.5%) | 37 (90.2%) | 34 (80.9%) | 0.35 |
Her2 positive | 12 (14.4%) | 5 (12.2%) | 7 (16.7%) | 0.75 |
Neoadjuvant chemotherapy | 9 (10.8%) | 5 (12.2%) | 4 (9.5%) | 0.72 |
Characteristic | Total (n = 83) | Group A—2020 (n = 41) | Group B—2019 (n = 42) | p Value |
---|---|---|---|---|
Waiting time for surgery | 47.8 ± 12.6 | 49.1 ± 12.6 | 46.4 ± 11.6 | 0.38 |
Type of surgery | <0.001 | |||
BCS | 61 (73.5%) | 32 (78.0%) | 29 (69.0%) | |
Mastectomy alone | 10 (12.0%) | 9 (22.0%) | 1 (2.4%) | |
Mastectomy + IR | 12 (14.5%) | 0 (0%) | 12 (28.6%) | |
Sentinel node biopsy | 64 (77.1%) | 32 (78.0%) | 32 (76.2%) | 0.84 |
Regional nerve blocks | 39 (47.0%) | 1 (2.4%) | 38 (90.5%) | <0.001 |
Hospital stay | 2.0 ± 1.7 | 1.5 ± 1.02 | 2.5 ± 2.0 | 0.008 |
Waiting time for postoperative oncological consultation | 24.0 ± 4.6 | 24.9 ± 4.6 | 23.1 ± 4.5 | 0.74 |
Waiting time for chemotherapy | 44.5 ± 8.5 | 42.8 ± 10.1 | 45.4 ± 8.0 | 0.58 |
Waiting time for radiotherapy consultation | 26.0 ± 3.4 | 26.1 ± 3.5 | 25.9 ± 3.4 | 0.77 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Fancellu, A.; Sanna, V.; Rubino, C.; Ariu, M.L.; Piredda, C.; Piana, G.Q.; Cottu, P.; Spanu, A.; Cossu, A.; Deiana, G.; et al. The COVID-19 Outbreak May Be Associated to a Reduced Level of Care for Breast Cancer. A Comparative Study with the Pre-COVID Era in an Italian Breast Unit. Healthcare 2020, 8, 474. https://doi.org/10.3390/healthcare8040474
Fancellu A, Sanna V, Rubino C, Ariu ML, Piredda C, Piana GQ, Cottu P, Spanu A, Cossu A, Deiana G, et al. The COVID-19 Outbreak May Be Associated to a Reduced Level of Care for Breast Cancer. A Comparative Study with the Pre-COVID Era in an Italian Breast Unit. Healthcare. 2020; 8(4):474. https://doi.org/10.3390/healthcare8040474
Chicago/Turabian StyleFancellu, Alessandro, Valeria Sanna, Corrado Rubino, Maria Laura Ariu, Claudia Piredda, Gian Quirico Piana, Pietrina Cottu, Angela Spanu, Antonio Cossu, Giulia Deiana, and et al. 2020. "The COVID-19 Outbreak May Be Associated to a Reduced Level of Care for Breast Cancer. A Comparative Study with the Pre-COVID Era in an Italian Breast Unit" Healthcare 8, no. 4: 474. https://doi.org/10.3390/healthcare8040474
APA StyleFancellu, A., Sanna, V., Rubino, C., Ariu, M. L., Piredda, C., Piana, G. Q., Cottu, P., Spanu, A., Cossu, A., Deiana, G., & Porcu, A. (2020). The COVID-19 Outbreak May Be Associated to a Reduced Level of Care for Breast Cancer. A Comparative Study with the Pre-COVID Era in an Italian Breast Unit. Healthcare, 8(4), 474. https://doi.org/10.3390/healthcare8040474